NCT02357524View on ClinicalTrials.gov

Oritavancin on the Results of Multiple Coagulation Tests in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Healthy Volunteers
Interventions
DRUG

Oritavancin

Trial Locations (1)

8011

Christchurch

Sponsors
All Listed Sponsors
collaborator

Christchurch Clinical Studies Trust Ltd

INDUSTRY

lead

Melinta Therapeutics, Inc.

INDUSTRY

NCT02357524 - Oritavancin on the Results of Multiple Coagulation Tests in Healthy Volunteers | Biotech Hunter | Biotech Hunter